Attovia Therapeutics, Inc. Common Stock Defensive Interval Ratio
Attovia Therapeutics, Inc. Common Stock defensive interval ratio. Attovia Therapeutics, Inc. Common Stock (ATTO) has a Defensive Interval Ratio of 2381 days as of June 2026. Defensive assets of $82.30 Million (cash $-, short-term investments $82.30 Million, receivables $-) cover 2381 days of daily cash needs of $34.56K/day. See Attovia Therapeutics, Inc. Common Stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Attovia Therapeutics, Inc. Common Stock (2024–2025)
Defensive interval ratio of Attovia Therapeutics, Inc. Common Stock from 2024 to 2025. This chart shows how Attovia Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 2381 days, meaning defensive assets of $82.30 Million can fund 2381 days of operations without new revenue. Check how resilient are Attovia Therapeutics, Inc. Common Stock's assets to evaluate the company's liquid asset resilience ratio.
Attovia Therapeutics, Inc. Common Stock Defensive Interval Ratio by Year (2024–2025)
Attovia Therapeutics, Inc. Common Stock defensive interval ratio by year from 2024 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Attovia Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see ATTO asset base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3716 days | $112.08 Million | $30.16K/day | $- | $112.08 Million | ▲ +1888 days |
| 2024 | 1829 days | $38.69 Million | $21.16K/day | $- | $38.69 Million | — |